Arlington Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History

Arlington Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$700.03 - $830.35 $7,000 - $8,303	-10 Reduced 76.92%	3 $2,000
Q1 2023 Apr 26, 2023	BUY	$680.49 - $826.97 $8,846 - $10,750	13 New	13 $10,000
Q1 2022 Apr 14, 2022	SELL	$595.12 - $698.43 $12,497 - $14,667	-21 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$543.48 - $670.97 $42,391 - $52,335	-78 Reduced 78.79%	21 $13,000
Q3 2021 Oct 15, 2021	BUY	$574.03 - $680.96 $56,828 - $67,415	99 New	99 $60,000
Q2 2020 Jul 13, 2020	SELL	$493.32 - $643.92 $7,399 - $9,658	-15 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$336.18 - $494.43 $2,689 - $3,955	8 Added 114.29%	15 $7,000
Q4 2019 Jan 16, 2020	BUY	$274.13 - $376.51 $1,918 - $2,635	7 New	7 $3,000
Q1 2019 Apr 05, 2019	SELL	$372.08 - $439.57 $2,604 - $3,076	-7 Closed	0 $0
Q4 2018 Jan 10, 2019	BUY	$335.82 - $403.04 $2,350 - $2,821	7 New	7 $3,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.